Josephine Baker

2.0k total citations
10 papers, 241 citations indexed

About

Josephine Baker is a scholar working on Pathology and Forensic Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Josephine Baker has authored 10 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Josephine Baker's work include Multiple Sclerosis Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Polyomavirus and related diseases (2 papers). Josephine Baker is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Polyomavirus and related diseases (2 papers). Josephine Baker collaborates with scholars based in Australia, United Kingdom and Sweden. Josephine Baker's co-authors include Helmut Butzkueven, Trevor J. Kilpatrick, Gary F. Egan, Mark S. Stein, Peter Mitchell, Orla Gray, Scott Kolbe, Leonard C. Harrison, Michael Ditchfield and Ai‐Lan Nguyen and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and JAMA Neurology.

In The Last Decade

Josephine Baker

9 papers receiving 236 citations

Peers

Josephine Baker
Carla Nunes Portugal
Stephanie Licata United States
Jamie McDonald United States
Katy Murray United Kingdom
Josephine Baker
Citations per year, relative to Josephine Baker Josephine Baker (= 1×) peers Kristin Wesnes

Countries citing papers authored by Josephine Baker

Since Specialization
Citations

This map shows the geographic impact of Josephine Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josephine Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josephine Baker more than expected).

Fields of papers citing papers by Josephine Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josephine Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josephine Baker. The network helps show where Josephine Baker may publish in the future.

Co-authorship network of co-authors of Josephine Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Josephine Baker. A scholar is included among the top collaborators of Josephine Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josephine Baker. Josephine Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ray, Jason C., Stuart J. McDonald, Marian Todaro, et al.. (2025). The impact of CGRP monoclonal antibodies on cytokine expression in chronic migraine: a cohort study. Journal of Neurology. 272(10). 649–649.
2.
Sharmin, Sifat, Vivien Li, Ai‐Lan Nguyen, et al.. (2021). Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study. CNS Drugs. 35(8). 907–918. 30 indexed citations
3.
Jokubaitis, Vilija, Jim Stankovich, Josephine Baker, et al.. (2021). High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients. Therapeutic Advances in Neurological Disorders. 14. 1280220483–1280220483. 9 indexed citations
4.
Li, Vivien, Ai‐Lan Nguyen, Izanne Roos, et al.. (2020). Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia. Multiple Sclerosis and Related Disorders. 46. 102516–102516. 8 indexed citations
5.
Gresle, Melissa, Margaret A. Jordan, Jim Stankovich, et al.. (2020). Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells. Life Science Alliance. 3(7). e202000650–e202000650. 27 indexed citations
6.
Carey, John P., Josephine Baker, Nicola Taylor, et al.. (2020). Fast and safe: Optimising multiple sclerosis infusions during COVID-19 pandemic. Multiple Sclerosis and Related Disorders. 47. 102642–102642. 10 indexed citations
7.
Nguyen, Ai‐Lan, Tomáš Kalinčík, Alessio Signori, et al.. (2020). Association of Pregnancy With the Onset of Clinically Isolated Syndrome. JAMA Neurology. 77(12). 1496–1496. 19 indexed citations
8.
Walt, Anneke van der, Jeremy Yuvaraj, Jim Stankovich, et al.. (2019). 020 Increased risk of an abnormal cervical screening test in women with MS exposed to high-efficacy disease-modifying treatments. Journal of Neurology Neurosurgery & Psychiatry. 90(e7). A7.3–A7. 1 indexed citations
9.
Stein, Mark S., Orla Gray, Josephine Baker, et al.. (2011). A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 77(17). 1611–1618. 136 indexed citations
10.
Baker, Josephine. (1997). J'ai deux amours. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026